Alexandra Okmian Sanderovich | Senior Business Development and Investor Relations Manager |
Dror Ben-Asher | Chief Executive Officer |
Guy Goldberg | Chief Business Officer |
Gilead Raday | Chief Operating Officer |
Rob Jackson | Senior VP, Sales & Marketing |
Micha Ben Chorin | Chief Financial Officer |
Brandon Folkes | Cantor Fitzgerald |
David Hoang | SMBC |
Boobalan Pachaiyappan | H.C. Wainwright |
Good day and welcome to the RedHill Biopharma’s Fourth Quarter and Full Year 2021 Financial Results Conference Call. All participants are in a listen-only mode. After the speakers’ presentation, there’ll be a question-and-answer session. [Operator Instructions] At this time, I would like to introduce the conference call, RedHill’s CEO, Dror Ben-Asher; Guy Goldberg, Chief Business Officer; Gilead Raday, Chief Operating Officer; Rob Jackson, Senior VP Sales & Marketing; Rick Scruggs, Chief Commercial Officer; and Micha Ben Chorin, Chief Financial Officer.
We have additional senior management team members available to answer questions during the Q&A session, including; Dr.